The aim of the present study was to evaluate the effect of a transgenic-induced chronic increase of Ang-(1-7) on the expression of inflammatory markers in adipose tissue and the metabolic profile in rats treated with high-fat diet. Research design and methods: Transgenic rats expressing an Ang-(1-7)-producing fusion protein (TGR L-3292) and Sprague Dawley (SD) control rats 4 weeks old were treated for 8 weeks with a high-fat diet. Food intake and body weight were measured once a week. Glucose-tolerance and insulin sensitivity tests were performed one week before the sacrifice. At the end of the experiment plasma lipid concentrations were measured in TGR and SD rats. Adipose tissue were weighted and corrected by the body weight. Proinflammatory markers in adipose tissue were analyzed using Western-blotting, real time-PCR and immunohistochemistry. Results: High-fat diet TGR rats presented increased HDL cholesterol levels and decreased abdominal fat mass, without changes in food intake. In addition, rats with increased Ang-(1-7) levels had lower body weight. Molecular analysis revealed decreased IL-1β and COX-2 in adipose tissue. Conclusions: Taken together, these results show that chronic high circulating angiotensin-(1-7) levels protect against metabolic stress induced by a high-fat diet decreasing the proinflammatory profile of adipose tissue.
Introduction
The prevalence of obesity is markedly rising in the world [1, 2] and is of considerable concern given the strong association between obesity, dietary fat intake and cardiometabolic diseases [3, 4] . Obesity is characterized by the accumulation of body fat. The body can adjust the mix of metabolic fuels it oxidizes so that alcohol, carbohydrate, and protein intakes are tightly regulated [4, 5] . In fact, the body can achieve carbohydrate and protein balances quickly. However, the body has a poor autoregulatory system for fat and an almost unlimited ability to store it [4] . Ultimately, obesity is caused by a positive energy balance and presently dietary fat intake is considered an important contributor to energy balance [4] . In addition, several authors consider obesity as a local and systemic inflammatory state associated with fat tissue over-production of many cytokines [6, 7] .
Adipose tissue is a complex population of cells that modulate not only adipose tissue biology, but also insulin sensitivity, the reproductive and endocrine systems, immunity, and inflammation [6] . There are several evidences suggesting that inflammation plays a major role in the initiation and maintenance of obesity through adipogenesis [2, [6] [7] [8] [9] [10] . White adipose tissue (WAT) becomes inflamed during adipose tissue hypertrophy due to infiltration by macrophages that secrete proinflammatory cytokines, including tumor necrosis factor TNF-α and IL-1β [11] . Another important enzyme involved in the production of several inflammatory mediators is cyclooxygenase 2 (COX2), which participates in obesity-related disturbances [12, 13] .
There is an increasing body of evidence showing the involvement of the renin-angiotensin (ANG) system (RAS) in inflammatory diseases [14] [15] [16] . Indeed, inflammatory cells have several components of the RAS [15] , which are upregulated in some diseases such as rheumatoid arthritis [16, 17] .
The RAS is classically described as an important modulator of blood pressure and hydroelectrolytic balance. More recent studies demonstrated the involvement of RAS with metabolic regulation [18, 19] . Results from experimental animals and humans suggest that obesity activates the RAS arm composed of ACE/Ang II/AT 1 [19, 20] . It is well known that adipose tissue expresses all components of the RAS and is markedly involved in obesity in which augmented expression of angiotensinogen and increased tissue and circulating levels of Ang II are observed [19] . On the other hand, recent studies indicate that the counterregulatory arm of RAS composed of the ACE2/Ang-(1-7)/Mas axis is able to produce an improvement in lipid and glucose metabolism decreasing body fat [21] [22] [23] [24] . The first study correlating Ang-(1-7) with metabolism showed that Mas receptor deficiency in FVB/N mice presented a metabolic state similar to the metabolic syndrome with dyslipidemia, hypertension, lower glucose tolerance and insulin sensitivity, hyperinsulinemia, hyperleptinemia, decreased glucose uptake in white adipose cells, and an increased adipose tissue mass [22] . A more recent study showed that transgenic rats with increased plasma Ang-(1-7) caused by overexpression of an Ang-(1-7)-producing fusion protein presented enhanced glucose tolerance, insulin sensitivity, and insulin-stimulated glucose uptake [25] . In addition, these transgenic rats presented decreased triglycerides and cholesterol levels, as well as a significant decrease in abdominal fat mass associated with augmented adiponectin production [25] .
In the present study, we sought to evaluate the expression of pro-inflammatory markers in adipose tissue and the metabolic profile in transgenic rats (TGR) presenting a significant increase in Ang-(1-7) plasma levels treated with high-fat diet. We used the model TGR(A1-7)3292 (TGR), which expresses an Ang-(1-7)-producing fusion protein, that results in a chronic elevation of circulating Ang-(1-7) levels [25, 26] .
Material and methods

Animals
Ten to twelve week-old male TGR and control Sprague Dawley (SD) rats were obtained from the transgenic animal facilities of the Laboratory of Hypertension, Federal University of Minas Gerais, Belo Horizonte, Brazil. All experimental protocols were performed in accordance with the international guidelines for animal care and approved by local authorities. The animals were maintained under controlled light and temperature conditions, and had free access to water and chow diet.
High-fat hypercaloric diet preparation
The high-fat diet was prepared according to the standards of the Association of Official Analytical Chemists used as described previously [27, 28] . Diet macronutrients were weighed and mixed homogeneously to form a soft dough. The diet was stored separately in a refrigerator (4°C) in hermetically sealed plastic boxes. The standard diet (Purina-Labina®) used for the regular maintenance of our rats is composed of 50.30% carbohydrates, 41.90% protein and 7.80% fat presenting a total of 2.18 kcal per 1 g of the diet. The high-fat diet was composed of 24.55% carbohydrates, 14.47% protein and 60.98% fat, presenting a total of 5.28 kcal per 1 g of the diet. All the high-fat diet components were purchased from Rhoster® LTDA (São Paulo SP; Brazil).
Measurements of body weight, food intake and tissue collection
The rats were individually housed and the food intake was measured every other week, during two consecutive days in order to obtain food efficiency (food intake / body weight).
Overnight fasted rats were killed by decapitation and samples of blood, epididymal and retroperitoneal white adipose tissues were collected, weighed and immediately frozen in dry ice and stored at − 80°C for posterior analysis.
Determination of blood parameters
Serum was obtained after centrifugation (3200 rpm for 10 min at 4°C). Total serum cholesterol and triglycerides were assayed using enzymatic kits (Doles®, Goias, Brazil). ELISA kits were used to measure serum adiponectin (AdipoGen®, Seoul, Korea), leptin (R&D systems®, Minneapolis, USA), and insulin (Linco Research Inc.®, USA) serum levels. Leptin and adiponectin secretion was calculated as serum levels normalized to fat tissue weight.
Glucose tolerance and insulin sensitivity tests
For the glucose-tolerance test, D-glucose (2 mg/g of body weight) was intraperitoneally injected into overnight fasted rats. Glucose levels from tail blood samples were monitored at 0, 15, 30, 60 and 120 min after injection using an Accu-Check glucometer (Roche Diagnostics Corp.®, Indianapolis, Indiana, USA). Insulin sensitivity test was performed on overnight fasted rats, after intraperitoneal injection of insulin (0.75 U/kg body weight-Sigma®, St Louis, MO, USA). Tail-blood samples were taken at time points 0, 15, 30 and 60 min after injection for the measurement of blood glucose levels.
Western blotting analysis
Proteins were extracted from epididymal adipose tissue samples (~300 mg) of TGR and SD rats and 30 μg of protein were resolved on SDS-PAGE gels (10%), transferred onto nitrocellulose membranes and blocked with 5% pure milk diluted in 1 × TBS. The blot was probed with COX2 enzyme antibody (Cell Signaling, USA; 1:1000), diluted in 1 × blocking buffer, washed in 1 × TBS with 1% of Tween 20, and then incubated with either IRDye 800 anti-goat secondary antibody (Rockland Immunochemicals®, Gilbertsville, Pa.) diluted to 1:10,000 in blocking buffer followed by further washes with PBS-Tween 20 and one wash in TBS. The blots were viewed using an infrared scanner from LICOR and analyzed using the Odyssey software.
Reverse transcription and real time PCR
The total RNA from the adipose tissues was prepared using the TRIzol reagent (Invitrogen Corp.®, San Diego, California, USA), treated with DNAse and reverse transcribed with M-MLV (Invitrogen Corp.®) using random hexamer primers. The levels of TNF-α, IL-1β mRNA were determined by real-time PCR using SYBR Green reagent (Appllied Biosystems®-USA) in an ABI Prism 7000 platform (Appllied Biosystems) with primers TNF-α-FW: 5′-TGC CTC AGC CTC TTC TCA TT-3′, and TNF-α-RV: 5′-CCC ATT TGG GAA CTT CTC CT-3′ and IL-1β-FW: 5′ATG GCA ACT GTC CCT GAA CTC ACC T-3′ and IL-1β-RV: 5′CAG GAC AGG TAT AGA TTC AAC CCC T-3′. Gene expression was normalized to the endogenous glyceraldehyde 3-phosphate dehydrogenase (GAPDH) FW: 5′-AAC GAC CCC TTC ATT GAC CTC and RV: 5′-CTT CCC ATT CTC AGC CTT GAC T. The relative comparative CT method of Livak and Schmittgen was applied to compare gene expression levels between groups, using the equation 2 − ΔΔCT [29] .
Hematoxylin and eosin staining
Epididymal fat tissues from TGR and SD rats were fixed in Bouin's solution and embedded in paraffin serially sectioned at 5 μm, stained with hematoxylin and eosin (HE), and evaluated under a conventional light microscope using an Olympus BX50 microscope (Tokyo, Japan). Images of fat tissue areas (×10 ocular and ×40 objective lenses) were captured with Evolution LC Color light camera (MediaCybernetics®, USA). A total area of 1.84 mm2, containing at least 100 fat cells for each sample, was measured using the NIS-ELEMENTS BR 2.30 Software (ESTADO, USA®).
Immunohistochemical reactions
For immunohistochemical reactions, 3 μm-thick sections were mounted on organosilane-coated slides. The primary mouse monoclonal antibodies against anti-IL1-β (clone H-153, ABCAM®, Cambridge, UK) and TNF-α (clone ab66579, ABCAM®, Cambridge, UK) cytokines were detected with the aid of an LSAB™ kit (product # K0690; Dako®, Glostrup, Denmark) employing chromogen diaminobenzidine for color development. Slides were finally counterstained with Mayer's hematoxylin and were mounted. Negative controls were obtained by substituting normal whole rabbit serum (product # X0902; Dako) for the primary antibodies. Positive controls were applied according to manufacturer's instructions. Only cells that presented brown cytoplasm staining were considered positive.
Statistical analysis
All data were transferred to the GraphPad Prism software (Version 4.0®; San Diego, California, USA) and submitted to specific tests with a statistic confidence of 95% (p b 0.05). Data are expressed as the mean ± SEM. The statistical significance of the differences in mean values between TGR and SD rats groups were assessed with the unpaired Student's t-test or two-way ANOVA (body weight, glucose tolerance and insulin sensibility tests).
Results
Body composition and food intake
As shown in Fig. 1 the body weight of TGR rats (N = 7) was lower than that of SD control rats (N = 7) during the period of the hyperlipidic diet treatment. At the end of the experiment the body weight was 418.3 ±19.78 g and 355.8 ± 12.34 g in SD and TGR respectively. Analysis of epididymal adipose tissue (0.01895±0.00153 g/g BW in SD vs 0.01303± 0.000848 g/g BW in TGR) and retroperitoneal adipose tissue (0.02024 ± 0.00133 g/g BW in SD vs 0.01305 ± 0.00146 g/g BW in TGR) demonstrated a reduced fat composition in TGR (Fig. 1) . Despite of a decreased fat mass, adipocyte area was not significantly diminished in TGR as demonstrated by the morphometrical assessment of the adipose tissue (Fig. 1) .
In order to confirm obesity induced by the high-fat diet we measured the body weight and adipose tissue weight of transgenic rats (TGRstd) and the Sprague Dawley rats (SDstd) treated with standard chow and we observed a significantly lower body weight in both TGRstd and SDstd when compared with those of high-fat fed animals as showed in Fig. 1 .
Every other week, food efficiency (food intake corrected by body weight), was measured and no significant alteration in food consumption was observed as shown in the table. The measurement was performed during two consecutive days and the result represents the average value for food consumption of the entire treatment period.
Lipid and glycemic parameters
Two weeks before the sacrifice, SD and TG presented similar insulin sensitivity and glucose tolerance (Fig. 2) . Total cholesterol, HDL cholesterol and triglycerides were measured in serum after sacrifice. We observed a significant increase in HDL cholesterol (40.55 ± 2.58 mg/dl in SD vs 55.49 ± 3.16 mg/dl in TGR rats) without alterations in the other plasma lipids (Fig. 2) .
Adipokines and insulin circulating levels
As shown in Table 1 serum circulating levels of insulin, adiponectin and leptin in TGR were similar to those of SD rats.
Inflammatory markers in adipose tissue
Epididymal adipose tissue was used to perform Western blot for COX2 and to determine the gene expression of proinflammatory cytokines. The results demonstrated a significant decrease in COX2 levels in the fat tissue of TGR (0.08741 ± 0.01877 AU) compared with that of the SD (0.2541 ± 0.0578 AU). An important reduction in IL-1β was also observed (1.07 ± 0.188 AU in SD vs 0.472 ± 0.109 AU in TGR). TNF-α expression was similar in both groups (1.226 ± 0.397 AU in SD vs 1.948 ± 0.511 AU in TGR). Immunohistochemistry analysis of adipose tissue illustrated the IL-1β and TNF-α results (Fig. 3) .
Discussion
In this study we took advantage of TGR-L3292 rats, which present elevated levels of circulating Ang-(1-7) in order to further address the metabolic role of this heptapeptide. The response to high-fat diet of SD and TGR rats was evaluated. The main differences observed in the TGR rats in comparison with the SD rats were: decreased body weight and adipose tissue mass associated with increased circulating HDL cholesterol and diminished pro-inflammatory markers in adipose tissue.
Despite an unchanged food intake and adipocyte diameter, TGR animals exhibited an important reduction in abdominal fat mass as compared with SD rats (epididymal and retroperitoneal adipose tissue) and decreased body weight gain. The absence of alterations in food intake indicates that the difference in fat mass was not induced by decreased appetite and probably it was due to changes in metabolic regulation. These results point out to a decrease in adipocyte cell proliferation, which is commonly induced by a high-fat diet, justifying the lower fat mass. Jayasooriya et al. [30] reported that a mouse lacking the ACE gene presented increased energy expenditure with reduced fat mass associated with increased Ang-(1-7) plasma levels [30] . Corroborating these findings, it was demonstrated that FVB/N mice with the deletion of the Ang-(1-7), Mas, receptor presented increased body fat with metabolic disturbance [22, 31] . These observations suggest a pivotal role of the RAS in fat mass control.
Recently it has been demonstrated that, at basal state, TGR rats present improved glycemic and lipid profiles [25] . However, in the previous study it was not evaluated whether this profile could be altered under metabolic stress or in a metabolic disease state. In the present study, we observed an important decrease in both adipose tissue mass and body weight despite of the high-fat diet feeding, in these rats. Nevertheless, the insulin sensitivity and glucose tolerance test, as well as the total cholesterol and triglyceride levels, were not improved in TGR rats when compared with those in SD control rats. The prevention of body weight and adiposity gain point to a potential regulatory role of Ang-(1-7) in metabolism. However, the beneficial effects can be attenuated by a continuous deleterious metabolic stimulus (high-fat diet) as evidenced by the non-altered insulin sensitivity and glucose tolerance in TGR. Previous studies have demonstrated the prejudicial effects of high-fat diet on metabolic performance [32] [33] [34] , which corroborate our results. Several studies reported that TNF-α and IL-1β are increased in obesity and this increase is correlated with numerous metabolic disorders [35] . In patients with obesity, adipose tissue is characterized by lowintensity inflammation and increased secretion of cytokines [8, 35, 36] . Tumor necrosis factor α (TNF-α), interleukin-6 and interleukin-1 β may be the most pernicious, since they alter adipose tissue function, influence adipogenesis, and are involved in the metabolic complications of obesity [8, 36] . A recent work by da Silveira et al. [16] demonstrated that the activation of the Ang-(1-7) Mas receptor exerts significant anti-inflammatory effects in two models of arthritis. Overall, genetic deletion of the receptor was associated with slight worsening of some aspects of arthritis in mice [16] . A mechanism that can partially explain this decreased pro-inflammatory profile is the regulation of the PPAR-gamma receptor by the Ang-(1-7)/Mas axis as described recently by Mario et.al using Mas-knokcout mice [31] .
IL-1β, a cytokine mainly produced by macrophages, endothelial cells, lymphocytes and epidermal cells, plays a role in the immune response and in inflammatory process, including obesity [37, 38] . IL-1β, IL6 and TNF-α [6, 39] are also produced by adipocytes and preadipocytes especially in unbalanced metabolic states [40, 41] . Circulating levels of IL-1β are correlated with the BMI of obese alcoholic subjects [42] and are increased in overweight and obese subjects compared with lean subjects [43] . In adipose tissue from obese subjects, the total release of IL1B was comparable with that of TNF-α [44] . The IL1 receptor is also overexpressed in the adipose tissue of mice with diet-induced and genetic obesity, as it is also in the subcutaneous adipose tissue of obese patients [45, 46] . All these findings support the hypothesis that IL1 signaling pathways, more specifically IL1B signaling in adipose tissue, may play an important role in obesity-linked insulin resistance. Silveira et al. showed in a mice model of arthritis that treatment with Mas receptor agonist, AVE, induced the decreased expression of IL-1β [16] . Accordingly, our results demonstrated an important decrease in IL-1B expression in adipose tissue of TGR animals pointing to an anti-inflammatory and antiobesogenic effect of Ang-(1-7). It remains to be determined whether this effect is due to an action of the peptide in adipocytes, in macrophages [47] or both. In addition, further studies are necessary to clarify the absence of changes in TNF-α expression in the TGR rats treated with a high-fat diet. One possibility to be tested in future studies is that plasma levels of Ang-(1-7) in our TGR (2-2.5-fold increase over the normal levels) may not be high enough to change TNF-α production in this metabolic condition.
Concerning the mechanisms involved in the prevention of a proinflammatory profile and the improvement of metabolism in TGR rats, despite the deleterious stimulus of high-fat diet, we hypothesize that decreased proinflammatory proteins in adipose tissue induced by Ang-(1-7) is able to improve metabolism. A recent study demonstrated that the IL-1 receptor is a key mediator of high-fat diet induced inflammation in adipose tissue and the deletion of the IL-1 receptor can partially protect against obesity-induced metabolic dysregulation in mice [48] . A similar mechanism can partially protect TGR rats against metabolic dysregulation.
A recent study suggested that cyclooxygenase (COX) 2-mediated inflammation in fat may be crucially involved in obesity-related insulin resistance and fatty liver in high-fat-fed rats, increasing oxidative stress [12] . Accordingly, Hsieh et al. demonstrated that inhibition of COX2 activation in high fat-induced obese rats leads to attenuation of adipose inflammation in both visceral and subcutaneous fat [13] . The present results demonstrated that increased circulating Ang-(1-7) is able to decrease the expression of COX-2 in adipose tissue of high-fat treated rats. Therefore, at least two pro-inflammatory mechanisms activated by high fat diet, increase in IL1B and COX-2, were attenuated in TGR.
A limitation of the present study was not to have evaluated the direct effect of high-fat diet on plasma Ang-(1-7) levels. However, our main focus was to evaluate the ability of increased circulating Ang- (1-7) , at the beginning of the diet treatment, to prevent WAT inflammation. In future studies it would be important to test the effect of different diet compositions on the RAS balance and whether treatment with Ang-(1-7) could revert the pro-inflamatory changes induced by a high fat diet.
Conclusions
In conclusion, this study shows that increased circulating Ang-(1-7) at the beginning of the diet treatment presents a protective effect against the proinflammatory profile in the adipose tissue of an overweight rat model induced by a high-fat diet. TGR animals presented decreased body weight, increased HDL cholesterol and decreased expression of COX-2 and IL-1β in abdominal fat. These results support the putative use of Ang-(1-7) as a novel therapeutic agent for the prevention and treatment of obesity-related disorders.
